Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests

• Published in: PLOS ONE Vol. 17; no. 5; p. e0267566
• Main Authors: Nishimura, Masashi, Sugawa, Satoshi, Ota, Shinichiro, Suematsu, Etsuko, Shinoda, Masahiro, Shinkai, Masaharu
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science (PLoS) 20.05.2022; Public Library of Science
• Subjects: Antibodies, Viral; Biology and life sciences; Complications and side effects; Coronaviruses; COVID-19; COVID-19 Serological Testing; COVID-19 vaccines; Cross Infection; Evaluation; Health care; Hospitals; Humans; Immunization; Immunoglobulin G; Infection; Japan; Laboratories; Medical personnel; Medical tests; Medicine; Medicine and health sciences; Morbidity; Nosocomial infection; Nosocomial infections; Nucleocapsids; Pandemics; Proteins; Public health; Q; R; Research Article; Respiratory diseases; Risk factors; SARS-CoV-2; Science; Serologic Tests; Serological tests; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus; Vaccination; Vaccines; Viral diseases; Japan; United States > US

To control COVID-19 pandemic is of critical importance to the global public health. To capture the prevalence in an accurate and timely manner and to understand the mode of nosocomial infection are essential for its preventive measure. We recruited 685 healthcare workers (HCW's) at Tokyo Shinag...